These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Structural basis for the presumptive atherothrombogenic action of lipoprotein(a). Facts and speculations. Scanu AM Biochem Pharmacol; 1993 Nov; 46(10):1675-80. PubMed ID: 8250952 [No Abstract] [Full Text] [Related]
4. Proposed mechanisms for binding of apo[a] kringle type 9 to apo B-100 in human lipoprotein[a]. Guevara J; Spurlino J; Jan AY; Yang CY; Tulinsky A; Prasad BV; Gaubatz JW; Morrisett JD Biophys J; 1993 Mar; 64(3):686-700. PubMed ID: 8386013 [TBL] [Abstract][Full Text] [Related]
5. Lipoprotein(a): structural implications for pathophysiology. Koschinsky ML; Marcovina SM Int J Clin Lab Res; 1997; 27(1):14-23. PubMed ID: 9144023 [TBL] [Abstract][Full Text] [Related]
6. [Lipoprotein(a). Its importance as an additional atherosclerosis marker]. Campos E Acta Med Port; 1997 Jan; 10(1):87-93. PubMed ID: 9245184 [TBL] [Abstract][Full Text] [Related]
7. Lipoprotein[a]: a predictor of atherosclerotic disease. Harris ED Nutr Rev; 1997 Mar; 55(3):61-4. PubMed ID: 9170891 [TBL] [Abstract][Full Text] [Related]
8. [Lipoprotein(a): a link between thrombosis and atherosclerosis?]. Hansen PR Ugeskr Laeger; 1993 May; 155(20):1527-30. PubMed ID: 8316983 [TBL] [Abstract][Full Text] [Related]
9. Kringle-dependent structural and functional polymorphism of apolipoprotein (a). Scanu AM; Edelstein C Biochim Biophys Acta; 1995 Apr; 1256(1):1-12. PubMed ID: 7742349 [No Abstract] [Full Text] [Related]
11. Lipoprotein(a): a new independent risk factor for atherosclerosis. Fulcher G Aust N Z J Med; 1992 Aug; 22(4):326-8. PubMed ID: 1445018 [No Abstract] [Full Text] [Related]
12. Lipoprotein(a). Link between structure and pathology. Scanu AM Ann Epidemiol; 1992 Jul; 2(4):407-12. PubMed ID: 1342291 [TBL] [Abstract][Full Text] [Related]
13. Lipoprotein (a) and vascular disease: thrombogenesis and atherogenesis. Lip GY; Jones AF QJM; 1995 Aug; 88(8):529-39. PubMed ID: 7648239 [TBL] [Abstract][Full Text] [Related]
14. Lipoprotein(a) concentration and apolipoprotein(a) size: A synergistic role in advanced atherosclerosis? Marcovina SM; Koschinsky ML Circulation; 1999 Sep; 100(11):1151-3. PubMed ID: 10484533 [No Abstract] [Full Text] [Related]
15. Lipoprotein(a): intrigues and insights. Hobbs HH; White AL Curr Opin Lipidol; 1999 Jun; 10(3):225-36. PubMed ID: 10431659 [TBL] [Abstract][Full Text] [Related]
16. Lipoprotein (a) and apoliprotein (a) isoform size in thyroid disease: the quest for the golden fleece. Duntas LH Thyroid; 2003 Apr; 13(4):345-6. PubMed ID: 12812213 [No Abstract] [Full Text] [Related]
17. Human lipoprotein (a)-induced reduction of platelet aggregation is not mediated by apolipoprotein A's lysine-binding regions. Barre D Front Biosci; 2003 Sep; 8():s1226-8. PubMed ID: 12957843 [TBL] [Abstract][Full Text] [Related]
18. Biochemical risk factors and patient's outcome: the case of lipoprotein(a). Lippi G; Guidi G Clin Chim Acta; 1999 Feb; 280(1-2):59-71. PubMed ID: 10090524 [TBL] [Abstract][Full Text] [Related]
19. High antifibrinolytic activity of lipoprotein(a) containing small apolipoprotein(a) isoforms. Anglés-Cano E Circulation; 2000 Dec; 102(25):E184-5. PubMed ID: 11120709 [No Abstract] [Full Text] [Related]
20. Structural and functional polymorphism of lipoprotein(a): biological and clinical implications. Scanu AM Clin Chem; 1995 Jan; 41(1):170-2. PubMed ID: 7813075 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]